Amgen Inc. has confirmed that it is stopping clinical trials for an experimental drug.Amgen Inc. has confirmed that it is stopping clinical trials for an experimental drug to treat Parkinson's disease Parkinson's disease or Parkinsonism, degenerative brain disorder first described by the English surgeon James Parkinson in 1817. When there is no known cause, the disease usually appears after age 40 and is referred to as Parkinson's disease. because of its potential to cause permanent brain damage. The Thousand Oaks Thousand Oaks, residential city (1990 pop. 104,352), Ventura co., S Calif., in a farm area; inc. 1964. Avocados, citrus, vegetables, strawberries, and nursery products are grown. biotech bi·o·tech n. Informal Biotechnology. biotech Noun short for biotechnology Noun 1. giant stopped trials in the fall of 2004, and will not provide its GDNF GDNF Glial-cell Line-Derived, Neurotrophic Factor GDNF Gesinnungsgemeinschaft der Neue Front (German) drug to 48 patients who were in those clinical trials. Amgen chief executive officer Kevin Sharer said that Amgen researchers spent several months reviewing the decision to stop the trials, and found the drug provided no medical benefits. "We have looked at this decision from every perspective scientific, medical and ethical. Our hearts truly go out to trial patients and their families, but we simply cannot allow trials to continue given the potential safety risks and the absence of proven benefit," Sharer said in a company release. "Encouraging patients to continue in the GDNF study deters Deters may refer to:
|
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion